GSK Q2 2024 Earnings Preview - MSN

GSK (NYSE:GSK) is scheduled to announce Q2 earnings results on Wednesday, July 31st, before market open. The consensus EPS Estimate is $0.98 (-97.5% Y/Y) and the consensus …

CouponFollow Extension

5%
OFF

GSK Q2 2024 Earnings Preview - MSN

1 week from now

GSK (NYSE:GSK) is scheduled to announce Q2 earnings results on Wednesday, July 31st, before market open. The consensus EPS Estimate is $0.98 (-97.5% Y/Y) and the consensus …

msn.com

£7
OFF

Second Quarter 2024 - GSK

1 week from now

GSK delivers continued strong performance and upgrades 2024 guidance Broad-based performance drives sales, core profit and core EPS growth: • Total Q2 2024 sales £7.9 billion …

gsk.com

12%
OFF

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance - MSN

1 week from now

GSK plc GSK reported core earnings of $1.09 per American depositary share (ADS) in second-quarter 2024, beating the Zacks Consensus Estimate of $1.00. Core earnings rose 12% year …

msn.com

13%
OFF

GSK Q2-2024 Earnings Call - Alpha Spread

1 week from now

GSK showcases strong Q2, upgrades 2024 guidance. GSK reported a strong Q2 with a 13% sales increase to GBP 7.9 billion and a 21% rise in core operating profit to GBP 2.5 billion. …

alphaspread.com

9%
OFF

GSK (GSK) Tops Q2 Earnings And Revenue Estimates - Yahoo Finance

1 week from now

Jul 31, 2024 · Glaxo (GSK) delivered earnings and revenue surprises of 9% and 4.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead …

yahoo.com

$1.10
OFF

GSK Stock Earnings: GSK Beats EPS, Beats Revenue For Q2 2024

1 week from now

Jul 31, 2024 · GSK (NYSE: GSK) just reported results for the second quarter of 2024.. GSK reported earnings per share of $1.10. This was above the analyst estimate for EPS of 99 …

investorplace.com

$1.16
OFF

GSK Q3 2024 Earnings Preview - MSN

1 week from now

GSK (NYSE:GSK) is scheduled to announce Q3 earnings results on Wednesday, October 30th, before market open. The consensus EPS Estimate is $1.16 and the consensus Revenue …

msn.com

$9.95
OFF

GSK (GSK) Tops Q2 Earnings And Revenue Estimates - Nasdaq

1 week from now

Jul 31, 2024 · GSK (GSK) Tops Q2 Earnings and Revenue Estimates July 31, 2024 — 07:05 am EDT. ... Biomedical and Genetics industry, posted revenues of $9.95 billion for the quarter …

nasdaq.com

$1.29
OFF

GSK Plc (NYSE:GSK) Q3 2024 Earnings Call Transcript - MSN

1 week from now

GSK plc (NYSE:GSK) Q3 2024 Earnings Call Transcript October 30, 2024 GSK plc beats earnings expectations. Reported EPS is $1.29, expectations were $1.23. Operator: Hello, …

msn.com

13%
OFF

GSK Plc (NYSE:GSK) Q1 2024 Earnings Call Transcript - MSN

1 week from now

Sales and profits grew double digits for the quarter, with sales up 13% to £7.4 billion, core operating profit up 35% to £2.4 billion, and core earnings per share up 37% to £43.1 all …

msn.com

$1.10
OFF

GSK Stock Earnings: GSK Beats EPS, Beats Revenue For Q2 2024

1 week from now

Jul 31, 2024 · GSK (NYSE: GSK) just reported results for the second quarter of 2024. GSK reported earnings per share of $1.10. This was above the analyst estimate for EPS of 99 cents.

investorplace.com

1%
OFF

NICE Q3 2024 Earnings Preview - MSN

1 week from now

NICE (NASDAQ:NICE) is scheduled to announce Q3 earnings results on Thursday, November 14th, before market open. The consensus EPS Estimate is $2.68 (+18.1% Y/Y) and the …

msn.com

0%
OFF

RLX Technology Q3 2024 Earnings Preview - MSN

1 week from now

RLX Technology (NYSE:RLX) is scheduled to announce Q3 earnings results on Friday, November 15th, before market open. The consensus EPS Estimate is $0.03 (+50.0% Y/Y) and …

msn.com

FAQs about GSK Q2 2024 Earnings Preview - MSN Coupon?

How did GSK perform in Q1 2024?

In Q1 2024, GSK reported earnings of $1.09 per share, which was $0.15 higher than the consensus estimate of $0.94. The company generated $9.34 billion in revenue, which was $0.36 billion more than analysts' expectations of $8.98 billion. GSK last released its earnings results on May 1st, 2024. ...

Will GSK's Q4 earnings be strong in 2023?

GSK's Q4 2023 and full-year 2023 earnings released later this month are expected to continue showing strength, especially with the successful launch of Arexvy, its respiratory disease vaccine. However, there are risks ahead too, as Zantac hearings are now underway and initial assessments of the company's earnings in 2024 are underwhelming. ...

What time will GSK's quarterly results be released?

A conference call and webcast for investors and analysts of the quarterly results will be hosted by Emma Walmsley, CEO, at 12 noon BST (US ET at 7am) on 31 July 2024. Presentation materials will be published on www.gsk.com prior to the webcast and a transcript of the webcast will be published subsequently. ...

Will GSK pay dividends in Q2 2024?

The Board has declared a second interim dividend for Q2 2024 of 15p per share (Q2 2023: 14p per share). Dividends remain an essential component of total shareholder return and GSK recognises the importance of dividends to shareholders. ...

How did GSK perform in Q2?

"GSK's momentum this year continues with excellent second quarter performance, reflecting strong operational execution and the strengthening breadth of our portfolio to both prevent and treat disease. Q2 sales grew in all areas, with Specialty Medicines in particular benefitting from new product launches in oncology and HIV. ...

How will GSK's growth impact 2024 Sterling core operating profit growth?

If exchange gains or losses were recognised at the same level as in 2023, the estimated impact on 2024 Sterling Core Operating Profit growth for GSK would be -6%. 1. Based on 2023 GSK continuing operations, including COVID-19 solutions 2. ...